Portfolio News
- October 23, 2012 Volubill Brings Real-Time Dynamic Policy and Session Control to Major US Wireless Market Leader’s M2M Solutions and Services
- October 22, 2012 - The Wall Street JournalPfizer in Deal to Acquire NextWave
- October 19, 2012 - CBS, New YorkGrowing Your Own Replacement Cartilage To Cure Knee Pain? (VIDEO CLIP)
- October 17, 2012 - Dow JonesCebix Raises $30.9M Ahead of New Clinical Studies for Diabetes-Complication Drug
- October 05, 2012 - San Francisco Business TimesAntibody drug maker KaloBios seeks $60 million in IPO
- October 02, 2012 - Enhanced Online NewsHistogenics Honored as a 2012 “Fierce 15” Company by FierceMedicalDevices
- September 18, 2012 Orange Reunion Chooses Volubill for Policy and Charging
- September 05, 2012 Amarin Announces Notification of Patent Allowances for U.S. Applications 12/702,889 and 13/349,153 Related to Vascepa(TM) and FDA Approved MARINE Indication
- September 05, 2012 Alvine’s ALV003 Receives Fast Track Designation From FDA for Potential Treatment of Celiac Disease
- September 04, 2012 Amarin Announces Notification of Patent Allowance for U.S. Application 13/282,145 Related to Vascepa(TM) and FDA Approved MARINE Indication Positions Vascepa for Exclusivity Into 2030
- August 28, 2012 Amarin Announces Additional Publication of MARINE Phase 3 Clinical Trial Results in the Journal of Clinical Lipidology
- July 27, 2012 - Dow Jones VentureWireHyperion Thera Goes Public as Investors Warm Up to Biotech
- July 26, 2012 Amarin Announces FDA Approval of Vascepa(TM) (icosapent ethyl) Capsules for the Reduction of Triglyceride Levels in Adult Patients With Severe Hypertriglyceridemia
- July 26, 2012 - Dow Jones VentureWireHyperion Therapeutics Opens Up 5% Post-IPO
- July 24, 2012 - Dow Jones VentureWireHistogenics Closes $49M Series A for Phase III Studies of Cartilage Implant
< More recent articles | Past articles >
Events
- October 28, 2013Mike Powell, BioNetwork West 2013 - "The Outlook for Traditional Venture Capital Firms: Evolving Trends and Opportunities"
- October 22, 2013Sofinnova Japan BioPharma Partnering Conference
- June 18, 2013Jennifer James, 2013 PEI Investor Relations Forum "Fundraising the next generation"
- March 25, 2013Mike Powell, Lecture at UCSF - "Lessons Learned in Venture Capital: What I learned the Hard Way, the Easy Way, and from the Entrepreneurs"
- February 12, 2013Anand Mehra Presents to Bio2Device Group
Media Contact
Jennifer James
VP of Marketing and Investor Relations
Sofinnova Ventures
jennifer@sofinnova.com
(650) 681-8429
